Pharmaceutical Anti-counterfeiting Technologies: Market Analysis 2011-2021


April 11, 2011
119 Pages - SKU: VSG6355087
License type:
Table of Contents Related Reports
Pharmaceutical Anti-counterfeiting Technologies: Market Analysis 2011-2021

  enlarge


What are the commercial prospects for pharmaceutical anti-counterfeiting technology? Our new report shows you that industry and market's revenue potential from 2011 to 2021.

There, you will assess anti-counterfeiting technologies, seeing trends and opportunities. We aim to save you time and aid your decisions through our research, analysis and discussions.

Our report shows you revenue prospects for pharma anti-counterfeiting technologies at total world, submarket and national levels to 2021. We discuss the anti-counterfeiting activities of companies such as Pfizer, J&J, GSK, Sanofi-Aventis, Novartis and AstraZeneca.

We also discuss the activities and potential of anti-counterfeiting specialists, such as NanoGuardian, Ahura Scientific, TruTag Technologies, Colorcon, Authentix, 3M, Cortegra and Covectra.

Our study forecasts revenues for radio frequency identification (RFID), pharmaceutical taggant, hologram/OVD, security ink and watermark technologies to 2021. You will see their market potentials.

Which pharma anti-counterfeiting technologies and national markets will provide the best opportunities from 2011 to 2021? What effects will governmental policies have? Our work gives answers you need.

Our new report provides data, analysis and opinion to benefit your research, calculations, meetings and presentations. To get that information please respond now.

Industry and market analysis to help your work - so you won't be left behind

Our report gives you revenue forecasts, growth rates and market shares. We also provide a SWOT/STEP analysis, review of companies and product developments, and opinions from our survey.

We include 67 tables and charts and three research interviews (shown in the accompanying lists). Our study helps you to understand pharma anti-counterfeiting activities this decade.

Pharmaceutical Anti-counterfeiting Technologies: Market Analysis 2011-2021 shows you revenue trends, opportunities and challenges

Our report gives you the following advantages:
  • You will receive hard data for the pharmaceutical anti-counterfeiting industry and market from 2010 to 2021
  • You will discover revenue forecasting for the overall world market to 2021
  • You will see revenue predictions for leading technologies - RFID, taggants, holograms/OVDs, security inks and watermarks - to 2021
  • You will assess anti-counterfeiting needs at world and regional level
  • You will find revenue predictions for leading geographical markets to 2021 (US, UK, Germany, France, Japan, Italy, Canada, Spain, China and India)
  • You will assess the implications of government mandates for product serialisation, seeing how these will affect the activities of pharma companies
  • You will assess leading companies in pharma anti-counterfeiting, discovering their activities, potential and commercial outlooks for the future
  • You will examine research and development, as well as up-and-coming technologies for tackling drug counterfeiting
  • You will investigate competition and opportunities that will influence revenues
  • You will see what will stimulate and restrain the industry and market
  • You will analyse opportunities for established companies and those seeking to enter the anti-counterfeiting technologies market
  • You will view opinion from our survey, including full interview transcripts.
That mix of quantitative and qualitative market analysis sets our report apart. Our analysis helps you to stay ahead in commercial knowledge.

Please Note: Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

The publisher is using a password system to access all reports. This password will be set up for single user and departmental licenses and will be emailed out to the client at the same time as the report. In the case of departmental site license purchases, the publisher requires all email addresses for the licensed users prior to fulfillment.


Additional Information


Report Excerpt

6.3.6 The Indian Anti-counterfeiting Technologies Market, 2010-2021

In 2010, India accounted for only 0.89% (Table 6.4 and Figure 6.3) of the global anti-counterfeiting technologies market and generated more than $4m in revenues (Table 6.13 and Figure 6.10). By 2015, India’s share of the global anti-counterfeiting technologies market will grow to 1.20% (Table 6.4 and Figure 6.4) and by 2021 this will grow to 1.60% (Table 6.4 and Figure 6.5). India has recently mandated that all exports from the country will carry a 2D Datamatrix label. This will act as a deterrent to criminals who are intent on exporting counterfeit brand medicines manufactured in India. The move will also improve the image of Indian exports, which has been hampered by the recent discovery of counterfeit Chinese medicines carrying the “Made in India” label. The mandate will be a market driver for the trade of anti-counterfeiting technologies in India. By 2015, the Indian anti-counterfeiting technologies market will generate approximately $12m in revenues (Table 6.13 and Figure 6.10). Visiongain forecasts a CAGR of 22.37% from 2010-2015. Further growth is expected from 2016-2021. Visiongain expects that anti-counterfeiting technologies based on 2D Datamatrix labels will account for the bulk of the market, but some companies will use 2D serialisation alongside RFID. By 2021, the Indian anti-counterfeiting technologies market is expected to generate $27m in revenues (Table 6.14 and Figure 6.10). The Indian market will grow with a CAGR of 14.13% from 2016-2021.

Companies Listed

3M
Ahura Scientific
Alfred P. Sloan Foundation
Alien Technology
Altegrity Risk International
AND Automation
Anvisa
Applied DNA Sciences
ARmark Authentication Technologies
AstraZeneca
Australian Therapeutic Goods Administration
Authentix
Avery Dennison
Axway
Camdata
Capsugel
Center for Medicine in the Public Interest
Cellular Bioengineering
CFC International
Colorcon
Cortegra
Covectra
Domino
Drugs Standard Control Organization
DuPont
Eli Lilly
Everest Holovisions
European Alliance for Access to Safe Medicines
European Commission
European Union
European Federation of Pharmaceutical Industries and Associations (EFPIA)
European Parliament
International Federation of Pharmaceutical Manufacturers & Associations
Food and Drug Administration (FDA)
FreightWatch
GIS
GlaxoSmithKline (GSK)
GS1
Heidelberg
Hewlett-Packard
Hologram Industries
Holomex
Image Solutions
Ingenia Technology
Inksure Technologies
Intermec
International Criminal Police Organization (INTERPOL)
International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
International Hologram Manufacturers Association
International Ink Company
Impinj
Johnson & Johnson
Kodak
Massachusetts Institute of Technology (MIT)
Medicines and Healthcare products Regulatory Agency (MHRA)
Menasha
Merck & Co.
MicroTag Temed
Microtrace Solutions
Motorola
NanoGuardian
NanoInk
Nanotech Security Corp
National Agency for Food and Drug Administration and Control
National Association of Boards of Pharmacies
Neri Labels
Nokia
Novartis
Novavision
Original1
Pacific Holographics
Parelec
PAREXEL
Pera Innovation
Pfizer
Pharmaceutical Research and Manufacturers of America (PhRMA)
Pharmaceutical Security Institute (PSI)
PricewaterhouseCoopers
Quality Brands Protection Committee
Reckitt Benckiser
Royal Pharmaceutical Society of Great Britain
Samsung
Sanofi-Aventis
Savi Technology
SICPA
Siemens
Simon Fraser University
Sun Chemical
Symbol Technologies
Systech
Tagsys RFID
Texas Instruments
Thermo Fisher Scientific
TruTag Technologies
United States Congress
United States Federal Government
United States Pharmacopeia
United Nations
WISeKey
World Customs Organization (WCO)
World Health Organization (WHO)
World Intellectual Property Organization (WIPO)
Zebra Technologies

More Regulation & Policy reports by Visiongain

Generic Drugs: World Market 2013-2023 by Visiongain
Your guide to trends and sales potential for generics Where's the generic drugs market heading? Visiongain's updated report gives you revenue predictions to 2023. ...
Pharmaceutical Contract Manufacturing: World Market Outlook 2012-2022 by Visiongain
How does the future look for pharmaceutical contract manufacturing? Visiongain's report gives you sales predictions to 2022. You find data, trends, opportunities and commercial prospects. ...
Lyophilisation for Pharmaceuticals: Products and Services Market 2012-2022 by Visiongain
What are the commercial prospects for pharmaceutical freeze drying? Visiongain's report gives you revenue predictions to 2022 for equipment, services and applications. You ...
Pharmacovigilance and Related Developments 2011-2021 by Visiongain
What does the future hold for pharmacovigilance? Visiongain's new report shows you prospects to 2021, discussing opportunities and developments. Assess events, opportunities and activities ...
See all reports like this >>

 
Research assistance
We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 
Related Markets

Regulation & Policy Reports
 
 

Share this report


Other tasks

 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!